{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:34:28Z","timestamp":1793687668518,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2022-MS-15, 2022-MS-16"],"award-info":[{"award-number":["2022-MS-15, 2022-MS-16"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2022-MS-15, 2022-MS-16"],"award-info":[{"award-number":["2022-MS-15, 2022-MS-16"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Second Hospital of Dalian Medical University-Dalian Institute of Chemical Technology Joint Medical-Industrial Innovation Fund","award":["DMU-2&DICP UN202309"],"award-info":[{"award-number":["DMU-2&DICP UN202309"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15553-0","type":"journal-article","created":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T09:09:59Z","timestamp":1756026599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development and validation of a machine learning-based survival prediction model for Asian glioblastoma patients using the SEER database and Chinese data"],"prefix":"10.1038","volume":"15","author":[{"given":"Denglin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhe","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningwei","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"15553_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11060-018-03073-z","volume":"142","author":"QT Ostrom","year":"2019","unstructured":"Ostrom, Q. T., Gittleman, H., Kruchko, C. & Barnholtz-Sloan, J. S. Primary brain and other central nervous system tumors in appalachia: regional differences in incidence, mortality, and survival. J. Neurooncol. 142, 27\u201338 (2019).","journal-title":"J. Neurooncol"},{"key":"15553_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe, S., Perry, A. & Butowski, N. A. Primary brain tumours in adults. Lancet 392, 432\u2013446 (2018).","journal-title":"Lancet"},{"key":"15553_CR3","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans, S. et al. Baranowska-Bosiacka, I. Epidemiology of glioblastoma Multiforme-Literature review. Cancers (Basel). 14, 2412 (2022).","journal-title":"Cancers (Basel)"},{"key":"15553_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","journal-title":"Acta Neuropathol."},{"key":"15553_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","volume":"15","author":"R Stupp","year":"2014","unstructured":"Stupp, R. et al. Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071\u2009\u2013\u200922072 study): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 15, 1100\u20131108 (2014).","journal-title":"Lancet Oncol."},{"key":"15553_CR6","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/S1470-2045(14)70011-7","volume":"15","author":"M Weller","year":"2014","unstructured":"Weller, M. et al. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol. 15, e395\u2013403 (2014).","journal-title":"Lancet Oncol."},{"key":"15553_CR7","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","volume":"314","author":"R Stupp","year":"2015","unstructured":"Stupp, R. et al. Maintenance therapy with Tumor-Treating fields plus Temozolomide vs Temozolomide alone for glioblastoma: A randomized clinical trial. JAMA 314, 2535\u20132543 (2015).","journal-title":"JAMA"},{"key":"15553_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(19)32998-8","volume":"395","author":"OJ Skrede","year":"2020","unstructured":"Skrede, O. J. et al. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study. Lancet 395, 350\u2013360 (2020).","journal-title":"Lancet"},{"key":"15553_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.gastro.2019.08.058","volume":"158","author":"C Le Berre","year":"2020","unstructured":"Le Berre, C. et al. Application of artificial intelligence to gastroenterology and hepatology. Gastroenterology 158, 76\u201394e2 (2020).","journal-title":"Gastroenterology"},{"key":"15553_CR10","doi-asserted-by":"publisher","first-page":"694306","DOI":"10.3389\/fpubh.2021.694306","volume":"9","author":"OJ Achilonu","year":"2021","unstructured":"Achilonu, O. J. et al. Predicting colorectal cancer recurrence and patient survival using supervised machine learning approach: A South African Population-Based study. Front. Public. Health. 9, 694306 (2021).","journal-title":"Front. Public. Health"},{"key":"15553_CR11","first-page":"vdab125","volume":"3","author":"M Kim","year":"2021","unstructured":"Kim, M. et al. Glioblastoma as an age-related neurological disorder in adults. Neurooncol Adv. 3, vdab125 (2021).","journal-title":"Neurooncol Adv."},{"key":"15553_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11940-005-0039-6","volume":"7","author":"MR Gilbert","year":"2005","unstructured":"Gilbert, M. R. & Loghin, M. The treatment of malignant gliomas. Curr. Treat. Options Neurol. 7, 293\u2013303 (2005).","journal-title":"Curr. Treat. Options Neurol."},{"key":"15553_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21037\/cco-22-18","volume":"11","author":"MJ Zhao","year":"2022","unstructured":"Zhao, M. J., Lu, T., Ma, C., Wang, Z. F. & Li, Z. Q. A narrative review on the management of glioblastoma in China. Chin. Clin. Oncol. 11, 29 (2022).","journal-title":"Chin. Clin. Oncol."},{"key":"15553_CR14","doi-asserted-by":"crossref","unstructured":"Ebad Ur Rehman, M. et al. Impact of prior cancer history on survival in brain malignancy: A propensity score-adjusted, population-based study. Cancer Rep (Hoboken) 7, e (2024). (1984).","DOI":"10.1002\/cnr2.1984"},{"key":"15553_CR15","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1200\/JCO.2017.76.7764","volume":"36","author":"LM Turcotte","year":"2018","unstructured":"Turcotte, L. M. et al. Risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: A review. J. Clin. Oncol. 36, 2145\u20132152 (2018). Risk.","journal-title":"J. Clin. Oncol."},{"key":"15553_CR16","doi-asserted-by":"publisher","first-page":"e321","DOI":"10.1016\/S1470-2045(13)70107-4","volume":"14","author":"DC Bowers","year":"2013","unstructured":"Bowers, D. C. et al. Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review. Lancet Oncol. 14, e321\u2013328 (2013).","journal-title":"Lancet Oncol."},{"key":"15553_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10143-016-0733-8","volume":"40","author":"R Yamanaka","year":"2017","unstructured":"Yamanaka, R. & Hayano, A. Secondary glioma following acute lymphocytic leukemia: therapeutic implications. Neurosurg. Rev. 40, 549\u2013557 (2017).","journal-title":"Neurosurg. Rev."},{"key":"15553_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00381-008-0631-7","volume":"24","author":"BL Pettorini","year":"2008","unstructured":"Pettorini, B. L. et al. Radiation-induced brain tumours after central nervous system irradiation in childhood: a review. Childs Nerv. Syst. 24, 793\u2013805 (2008).","journal-title":"Childs Nerv. Syst."},{"key":"15553_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","volume":"354","author":"MV Relling","year":"1999","unstructured":"Relling, M. V. et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354, 34\u201339 (1999).","journal-title":"Lancet"},{"key":"15553_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<269::AID-IJC1>3.0.CO;2-T","volume":"78","author":"MP Little","year":"1998","unstructured":"Little, M. P. et al. Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int. J. Cancer. 78, 269\u2013275 (1998).","journal-title":"Int. J. Cancer"},{"key":"15553_CR21","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/cncr.10595","volume":"94","author":"FC Maluf","year":"2002","unstructured":"Maluf, F. C., DeAngelis, L. M., Raizer, J. J. & Abrey, L. E. High-grade gliomas in patients with prior systemic malignancies. Cancer 94, 3219\u20133224 (2002).","journal-title":"Cancer"},{"key":"15553_CR22","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.27.0090","volume":"28","author":"AJ Taylor","year":"2010","unstructured":"Taylor, A. J. et al. Population-based risks of CNS tumors in survivors of childhood cancer: the British childhood cancer survivor study. J. Clin. Oncol. 28, 5287\u20135293 (2010).","journal-title":"J. Clin. Oncol."},{"key":"15553_CR23","doi-asserted-by":"publisher","first-page":"20140211","DOI":"10.1259\/bjr.20140211","volume":"87","author":"M Chojnacka","year":"2014","unstructured":"Chojnacka, M. et al. Second brain tumors following central nervous system radiotherapy in childhood. Br. J. Radiol. 87, 20140211 (2014).","journal-title":"Br. J. Radiol."},{"key":"15553_CR24","doi-asserted-by":"publisher","first-page":"14145","DOI":"10.1007\/s00432-023-05232-w","volume":"149","author":"X Niu","year":"2023","unstructured":"Niu, X., Chang, T., Yang, Y. & Mao, Q. Prognostic nomogram models for predicting survival probability in elderly glioblastoma patients. J. Cancer Res. Clin. Oncol. 149, 14145\u201314157 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"15553_CR25","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.3390\/cancers16213614","volume":"16","author":"M Karabacak","year":"2024","unstructured":"Karabacak, M., Patil, S., Gersey, Z. C., Komotar, R. J. & Margetis, K. Radiomics-Based machine learning with natural gradient boosting for continuous survival prediction in glioblastoma. Cancers (Basel). 16, 3614 (2024).","journal-title":"Cancers (Basel)"},{"key":"15553_CR26","doi-asserted-by":"publisher","first-page":"24350","DOI":"10.1038\/s41598-024-75018-8","volume":"14","author":"W Li","year":"2024","unstructured":"Li, W. et al. Pathomics models for CD40LG expression and prognosis prediction in glioblastoma. Sci. Rep. 14, 24350 (2024).","journal-title":"Sci. Rep."},{"key":"15553_CR27","doi-asserted-by":"crossref","unstructured":"Zhou, Q. et al. Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas. Strahlenther Onkol. 201, 398-410 (2024).","DOI":"10.1007\/s00066-024-02283-x"},{"key":"15553_CR28","first-page":"79","volume":"13","author":"P Azimi","year":"2024","unstructured":"Azimi, P., Yazdanian, T., Zohrevand, A. & Ahmadiani, A. Predicting survival in glioblastoma using gene expression databases: A neural network analysis. Int. J. Mol. Cell. Med. 13, 79\u201390 (2024).","journal-title":"Int. J. Mol. Cell. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15553-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:48:21Z","timestamp":1757422101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15553-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15553-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Second Affiliated Hospital of Dalian Medical University approved the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}],"article-number":"31114"}}